|
|
Antwerp/Marseille, 4 December 2019, 6:45 AM CET
Imcheck Therapeutics raises USD 53 million, Gimv increases its
investment in the immunooncology space
In a Series B financing round of USD 53 million, Gimv is increasing its investment in French ImCheck
Therapeutics www.imchecktherapeutics.com, an emerging player in the field of cancer and autoimmune
... See more |
|
| |
|
| |
|
|
Antwerp, 21 November 2019, 7:00 CET
Further growth and continuing strong portfolio results
Managing Director Koen Dejonckheere, on the past halfyears results:
“With a persistent strong pace of investment, Gimv grew its portfolio further to its present
level of EUR 1.2 billion.
Our portfolio companies achieved attractive results in an uncertain... See more |
|
| |
|
| |
|
|
Antwerpen / Paris, 14 October 2019, 8:00 CET
Eric de Montgolfier appointed as CEO of Invest Europe
14 October 2019, Invest Europe appoints Eric de Montgolfier as new CEO to lead the world’s largest association
of private capital providers and investors. We sincerely thank Eric currently Head Gimv France for the past 5
years at Gimv and wish him all the best... See more |
|
| |
|
| |
|
|
Antwerp, 5 September, 8:00 AM CET
iSTAR Medical announces EUR 40.1 million financing round lead by
Gimv to support further development of an innovative glaucoma
treatment
iSTAR Medical SA, a Wavrebased private medical device company developing novel
ophthalmic implants for the treatment of glaucoma, today announces the completion of a EUR
40.1... See more |
|
| |
|
| |
|
|
Antwerp BE, 30 July 2019, 8:00 CET
AgroSavfe raises EUR 35 million, Gimv invests additional resources for
further development of biocontrols as a new standard for sustainable
crop protection
Gimv is increasing its commitment to AgroSavfe, an innovative food and agrobiotech company
developing environmentally friendly plant protection products. As... See more |
|
| |
|
| |
|
|
Search :
